National Health Investors, Inc. (NHI) PT Raised to $82.00

National Health Investors, Inc. (NYSE:NHI) had its price objective hoisted by stock analysts at Stifel Nicolaus from $80.00 to $82.00 in a research note issued to investors on Wednesday. The brokerage currently has a “buy” rating on the real estate investment trust’s stock. Stifel Nicolaus’ price objective points to a potential upside of 4.45% from the stock’s previous close.

Other equities research analysts have also recently issued reports about the company. ValuEngine cut National Health Investors from a “buy” rating to a “hold” rating in a report on Tuesday, June 13th. Bank of America Corporation cut National Health Investors from a “neutral” rating to an “underperform” rating and set a $76.00 target price for the company. in a report on Monday, May 22nd. Zacks Investment Research cut National Health Investors from a “buy” rating to a “hold” rating in a report on Tuesday, May 16th. Finally, Cantor Fitzgerald reiterated a “neutral” rating and issued a $75.00 target price on shares of National Health Investors in a report on Tuesday, February 21st. One research analyst has rated the stock with a sell rating, five have issued a hold rating and two have given a buy rating to the company. The company has an average rating of “Hold” and an average price target of $79.17.

Analyst Recommendations for National Health Investors (NYSE:NHI)

National Health Investors (NHI) opened at 78.51 on Wednesday. The company has a market cap of $3.22 billion, a P/E ratio of 19.07 and a beta of 0.60. The firm has a 50-day moving average price of $75.67 and a 200-day moving average price of $74.03. National Health Investors has a 12-month low of $66.31 and a 12-month high of $82.53.

National Health Investors (NYSE:NHI) last issued its earnings results on Tuesday, May 9th. The real estate investment trust reported $1.10 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $1.26 by $0.16. National Health Investors had a return on equity of 13.36% and a net margin of 63.72%. The firm had revenue of $66.39 million during the quarter, compared to analysts’ expectations of $65.42 million. During the same quarter in the prior year, the company posted $1.16 earnings per share. National Health Investors’s quarterly revenue was up 12.5% compared to the same quarter last year. On average, equities research analysts forecast that National Health Investors will post $3.73 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Thursday, August 10th. Stockholders of record on Friday, June 30th will be given a $0.95 dividend. This represents a $3.80 annualized dividend and a dividend yield of 4.84%. The ex-dividend date is Wednesday, June 28th. National Health Investors’s payout ratio is 92.23%.

COPYRIGHT VIOLATION WARNING: This story was originally published by Mideast Time and is the property of of Mideast Time. If you are reading this story on another publication, it was stolen and republished in violation of U.S. and international copyright & trademark laws. The correct version of this story can be read at https://www.mideasttime.com/national-health-investors-inc-nhi-pt-raised-to-82-00/1804743.html.

Several hedge funds and other institutional investors have recently added to or reduced their stakes in NHI. Credit Agricole S A raised its position in National Health Investors by 40.9% in the fourth quarter. Credit Agricole S A now owns 27,455 shares of the real estate investment trust’s stock valued at $2,036,000 after buying an additional 7,972 shares during the last quarter. Guggenheim Capital LLC raised its position in National Health Investors by 130.7% in the fourth quarter. Guggenheim Capital LLC now owns 65,111 shares of the real estate investment trust’s stock valued at $4,829,000 after buying an additional 36,885 shares during the last quarter. GW&K Investment Management LLC raised its position in National Health Investors by 1.2% in the first quarter. GW&K Investment Management LLC now owns 641,556 shares of the real estate investment trust’s stock valued at $46,596,000 after buying an additional 7,335 shares during the last quarter. Adams Diversified Equity Fund Inc. raised its position in National Health Investors by 3.0% in the first quarter. Adams Diversified Equity Fund Inc. now owns 13,700 shares of the real estate investment trust’s stock valued at $995,000 after buying an additional 400 shares during the last quarter. Finally, Daiwa Securities Group Inc. raised its position in National Health Investors by 1.7% in the first quarter. Daiwa Securities Group Inc. now owns 3,200 shares of the real estate investment trust’s stock valued at $232,000 after buying an additional 55 shares during the last quarter. 69.51% of the stock is owned by hedge funds and other institutional investors.

About National Health Investors

National Health Investors, Inc is a self-managed real estate investment trust (REIT) specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company is engaged in the business of owning and financing healthcare properties.new TradingView.widget({ “height”: 400, “width”: 625, “symbol”: “NHI”, “interval”: “D”, “timezone”: “Etc/UTC”, “theme”: “White”, “style”: “1”, “locale”: “en”, “toolbar_bg”: “#f1f3f6”, “enable_publishing”: false, “hideideas”: true, “referral_id”: “2588”});

Receive News & Ratings for National Health Investors Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors Inc. and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply

 
© 2006-2017 Mideast Time.